This brand name is authorized in Austria, Brazil, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States, South Africa
The drug NASONEX contains one active pharmaceutical ingredient (API):
1
Mometasone
UNII MTW0WEG809 - MOMETASONE FUROATE MONOHYDRATE
|
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NASONEX Nasal Spray, Suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
NASONEX Nasal spray | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R01AD09 | Mometasone | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 527315120017617, 527315120017717 |
Country: CA | Health Products and Food Branch | Identifier(s): 02238465 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00055509, 02193150, 05049548, 05120832, 10663256 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 22.376-1-08-05 |
Country: EE | Ravimiamet | Identifier(s): 1028966, 1726501, 1726512, 1726523, 1820135, 1820168, 1823554, 1823587 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61905, BE190854, BE190854IP |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 474551, 474643 |
Country: FR | Base de données publique des médicaments | Identifier(s): 63566855 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 139359, 143237, 26794 |
Country: HK | Department of Health Drug Office | Identifier(s): 43556 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-032470068 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 31587, 35235, 67120, 67145 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1329710Q1027, 1329710Q2023 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003843, 1068854, 1077869, 1077870, 1079727, 1081256, 1082883, 1085547, 1085569, 1089255, 1089256 |
Country: MT | Medicines Authority | Identifier(s): MA031/01901, PI770/10401A, PI908/12702A |
Country: NL | Z-Index G-Standaard | Identifier(s): 14269961 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 52434 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 7958 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100080562, 100157980, 100346267, 100351831, 100355964, 100363923, 100370544, 100384078, 100386634, 100460850, 100467170 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68334001, W68334002, W68334003, W68334004 |
Country: SG | Health Sciences Authority | Identifier(s): 10763P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6523111 |
Country: US | FDA, National Drug Code | Identifier(s): 0085-1288 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/21.5.1/0157, 36/21.5.1/0414 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.